BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 19451088)

  • 21. Proteomics-based identification of alpha1-antitrypsin and haptoglobin precursors as novel serum markers in infiltrating ductal breast carcinomas.
    Hamrita B; Chahed K; Trimeche M; Guillier CL; Hammann P; Chaïeb A; Korbi S; Chouchane L
    Clin Chim Acta; 2009 Jun; 404(2):111-8. PubMed ID: 19306859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteomic analysis of nipple aspirate fluid from women with early-stage breast cancer using isotope-coded affinity tags and tandem mass spectrometry reveals differential expression of vitamin D binding protein.
    Pawlik TM; Hawke DH; Liu Y; Krishnamurthy S; Fritsche H; Hunt KK; Kuerer HM
    BMC Cancer; 2006 Mar; 6():68. PubMed ID: 16542425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prohibitin identified by proteomic analysis of prostate biopsies distinguishes hyperplasia and cancer.
    Ummanni R; Junker H; Zimmermann U; Venz S; Teller S; Giebel J; Scharf C; Woenckhaus C; Dombrowski F; Walther R
    Cancer Lett; 2008 Aug; 266(2):171-85. PubMed ID: 18384941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteomics profiling of microdissected low- and high-grade prostate tumors identifies Lamin A as a discriminatory biomarker.
    Skvortsov S; Schäfer G; Stasyk T; Fuchsberger C; Bonn GK; Bartsch G; Klocker H; Huber LA
    J Proteome Res; 2011 Jan; 10(1):259-68. PubMed ID: 20977276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of serological proteomic methods to find biomarkers associated with breast cancer.
    Rui Z; Jian-Guo J; Yuan-Peng T; Hai P; Bing-Gen R
    Proteomics; 2003 Apr; 3(4):433-9. PubMed ID: 12687611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Proteomics and breast cancer].
    Mathelin C; Tomasetto C; Cromer A; Rio MC
    Gynecol Obstet Fertil; 2006 Dec; 34(12):1161-9. PubMed ID: 17123853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteomic analysis in human breast cancer: identification of a characteristic protein expression profile of malignant breast epithelium.
    Hudelist G; Singer CF; Pischinger KI; Kaserer K; Manavi M; Kubista E; Czerwenka KF
    Proteomics; 2006 Mar; 6(6):1989-2002. PubMed ID: 16470630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Down-regulated expression of complement factor I: a potential suppressive protein for gastric cancer identified by serum proteome analysis.
    Liu W; Liu B; Xin L; Zhang Y; Chen X; Zhu Z; Lin Y
    Clin Chim Acta; 2007 Feb; 377(1-2):119-26. PubMed ID: 17067565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glutamine synthetase as an early marker for hepatocellular carcinoma based on proteomic analysis of resected small hepatocellular carcinomas.
    Long J; Lang ZW; Wang HG; Wang TL; Wang BE; Liu SQ
    Hepatobiliary Pancreat Dis Int; 2010 Jun; 9(3):296-305. PubMed ID: 20525558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expanding the protein catalogue in the proteome reference map of human breast cancer cells.
    Pucci-Minafra I; Cancemi P; Fontana S; Minafra L; Feo S; Becchi M; Freyria AM; Minafra S
    Proteomics; 2006 Apr; 6(8):2609-25. PubMed ID: 16526084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of differentially expressed proteins of gamma-ray irradiated rat intestinal epithelial IEC-6 cells by two-dimensional gel electrophoresis and matrix-assisted laser desorption/ionisation-time of flight mass spectrometry.
    Bo Z; Yongping S; Fengchao W; Guoping A; Yongjiang W
    Proteomics; 2005 Feb; 5(2):426-32. PubMed ID: 15700242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proteomics-based identification of a group of apoptosis-related proteins and biomarkers in gastric cancer.
    Bai Z; Ye Y; Liang B; Xu F; Zhang H; Zhang Y; Peng J; Shen D; Cui Z; Zhang Z; Wang S
    Int J Oncol; 2011 Feb; 38(2):375-83. PubMed ID: 21165559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Detection and clinical significance of serum proteomic patterns of breast cancers by surface enhanced laser desorption/ionization time of flight mass spectrometry].
    Zhang GQ; Du J; Pang D
    Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):204-7. PubMed ID: 16875606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proteome analysis of human lung squamous carcinoma.
    Li C; Xiao Z; Chen Z; Zhang X; Li J; Wu X; Li X; Yi H; Li M; Zhu G; Liang S
    Proteomics; 2006 Jan; 6(2):547-58. PubMed ID: 16342241
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoantibody to tumor antigen, alpha 2-HS glycoprotein: a novel biomarker of breast cancer screening and diagnosis.
    Yi JK; Chang JW; Han W; Lee JW; Ko E; Kim DH; Bae JY; Yu J; Lee C; Yu MH; Noh DY
    Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1357-64. PubMed ID: 19423516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer.
    Pei H; Zhu H; Zeng S; Li Y; Yang H; Shen L; Chen J; Zeng L; Fan J; Li X; Gong Y; Shen H
    J Proteome Res; 2007 Jul; 6(7):2495-501. PubMed ID: 17542627
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surface-enhanced laser desorption/ionization time of flight mass spectrometry protein profiling identifies ubiquitin and ferritin light chain as prognostic biomarkers in node-negative breast cancer tumors.
    Ricolleau G; Charbonnel C; Lodé L; Loussouarn D; Joalland MP; Bogumil R; Jourdain S; Minvielle S; Campone M; Déporte-Fety R; Campion L; Jézéquel P
    Proteomics; 2006 Mar; 6(6):1963-75. PubMed ID: 16470659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteomic-based discovery and characterization of glycosylated eosinophil-derived neurotoxin and COOH-terminal osteopontin fragments for ovarian cancer in urine.
    Ye B; Skates S; Mok SC; Horick NK; Rosenberg HF; Vitonis A; Edwards D; Sluss P; Han WK; Berkowitz RS; Cramer DW
    Clin Cancer Res; 2006 Jan; 12(2):432-41. PubMed ID: 16428483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Case-control breast cancer study of MALDI-TOF proteomic mass spectrometry data on serum samples.
    van der Werff MP; Mertens B; de Noo ME; Bladergroen MR; Dalebout HC; Tollenaar RA; Deelder AM
    Stat Appl Genet Mol Biol; 2008; 7(2):Article2. PubMed ID: 18241195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Searching urinary tumor markers for bladder cancer using a two-dimensional differential gel electrophoresis (2D-DIGE) approach.
    Orenes-Piñero E; Cortón M; González-Peramato P; Algaba F; Casal I; Serrano A; Sánchez-Carbayo M
    J Proteome Res; 2007 Nov; 6(11):4440-8. PubMed ID: 17902641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.